Survival data of 78 patients who received radiotherapy were extracted, and the Kaplan‐Meier analysis showed that high expression of TRIB2 and MAP3K1 was conversely correlated with the poor survival of patients with glioma who were treated with radiotherapy (Figure 9A). This evidence concerns the gene TRIB2 and central nervous system cancer.